Phio Pharmaceuticals Corp. Common Stock
PHIO •
Buy Open
Signal type
Buy
Status
Open
Open Price
$1.31
Stop Loss
$0.22
Performance
-1.53%
Days Open
23
Signal Setup
Signal Type Buy
Status Open
Open Date Mar 23, 2026
Open Price $1.31
Stop Loss $0.22
Timespan Day
Company Profile
Name Phio Pharmaceuticals Corp. Common Stock
Ticker PHIO
Market Cap $11.90M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $1.29
List Date May 10, 2012
Description
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
Website Open Company Website